OVAINFORM
Live / Applied — First extension granted (statement of use) (as of 17 Dec 2025)
What this means for you
Not registered yet, but its 21 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98866074
- Mark type
- Word mark
- Filed
- 21 Nov 2024
- Published for opposition
- 29 Apr 2025
- Attorney of record
- Melissa Hunter-Ensor
Goods and services
- Class 005 — Pharmaceuticals: Reagents, diagnostic preparations for medical purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing
Owner
- Aspira Women's Health Inc., Austin, TX, US
- Aspira Women's Health Inc., Austin, TX, US
Prosecution history
- 18 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Dec 2025 — SOU EXTENSION 1 GRANTED
- 17 Dec 2025 — SOU EXTENSION 1 FILED
- 17 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Apr 2025 — PUBLISHED FOR OPPOSITION
- 23 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Mar 2025 — ASSIGNED TO EXAMINER
- 31 Mar 2025 — ASSIGNED TO EXAMINER
- 30 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Nov 2024 — APPLICATION FILING RECEIPT MAILED
- 24 Nov 2024 — APPLICATION FILING RECEIPT MAILED
- 21 Nov 2024 — NEW APPLICATION ENTERED